Verweij PE - Search Results

1

Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis¹.

Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CSC, van der Spoel HI, Rijnders BJA, Dunbar A, Schouten JA, Lagrou K, Bourgeois M, Reynders M, van Regenmortel N, Rutsaert L, Lormans P, Feys S, Debavaye Y, Tamion F, Costa D, Maizel J, Dupont H, Chouaki T, Nseir S, Sendid B, Brüggemann RJM, van de Veerdonk FL, Wauters J, Verweij PE. Janssen NAF, et al. Among authors: verweij pe. Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14. Emerg Infect Dis. 2021. PMID: 34519638 Free PMC article.

2

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.

Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, Heinen C, Crépin B, Van Eldere J, Tabouret M, Donnelly JP, Verweij PE. Maertens JA, et al. Among authors: verweij pe. Clin Infect Dis. 2007 May 15;44(10):1329-36. doi: 10.1086/514349. Epub 2007 Apr 4. Clin Infect Dis. 2007. PMID: 17443470 Free article.

3

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.

Brüggemann RJ, Alffenaar JW, Blijlevens NM, Billaud EM, Kosterink JG, Verweij PE, Burger DM. Brüggemann RJ, et al. Among authors: verweij pe. Clin Infect Dis. 2009 May 15;48(10):1441-58. doi: 10.1086/598327. Clin Infect Dis. 2009. PMID: 19361301 Free article. Review.

4

Impact of therapeutic drug monitoring of voriconazole in a pediatric population.

Brüggemann RJ, van der Linden JW, Verweij PE, Burger DM, Warris A. Brüggemann RJ, et al. Among authors: verweij pe. Pediatr Infect Dis J. 2011 Jun;30(6):533-4. doi: 10.1097/INF.0b013e318204d227. Pediatr Infect Dis J. 2011. PMID: 21127454

5

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJ, Verweij PE. van der Linden JW, et al. Among authors: verweij pe. Emerg Infect Dis. 2011 Oct;17(10):1846-54. doi: 10.3201/eid1710.110226. Emerg Infect Dis. 2011. PMID: 22000354 Free PMC article.

6

Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.

Seyedmousavi S, Brüggemann RJ, Melchers WJ, Verweij PE, Mouton JW. Seyedmousavi S, et al. Among authors: verweij pe. Antimicrob Agents Chemother. 2013 Jan;57(1):303-8. doi: 10.1128/AAC.01430-12. Epub 2012 Oct 31. Antimicrob Agents Chemother. 2013. PMID: 23114773 Free PMC article.

7

Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.

van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders BJ, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE. van der Linden JW, et al. Among authors: verweij pe. Clin Infect Dis. 2013 Aug;57(4):513-20. doi: 10.1093/cid/cit320. Epub 2013 May 10. Clin Infect Dis. 2013. PMID: 23667263

8

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.

Seyedmousavi S, Mouton JW, Verweij PE, Brüggemann RJ. Seyedmousavi S, et al. Among authors: verweij pe. Expert Rev Anti Infect Ther. 2013 Sep;11(9):931-41. doi: 10.1586/14787210.2013.826989. Expert Rev Anti Infect Ther. 2013. PMID: 24053274 Review.

9

Azole resistance in Aspergillus fumigatus: a growing public health concern.

Vermeulen E, Lagrou K, Verweij PE. Vermeulen E, et al. Among authors: verweij pe. Curr Opin Infect Dis. 2013 Dec;26(6):493-500. doi: 10.1097/QCO.0000000000000005. Curr Opin Infect Dis. 2013. PMID: 24126719 Review.

10

Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens.

Seyedmousavi S, Brüggemann RJ, Melchers WJ, Verweij PE, Mouton JW. Seyedmousavi S, et al. Among authors: verweij pe. Antimicrob Agents Chemother. 2014 May;58(5):2964-7. doi: 10.1128/AAC.00053-14. Epub 2014 Feb 24. Antimicrob Agents Chemother. 2014. PMID: 24566183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

506 results

Search Page